GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medlive Technology Co 2192.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

6.59

+0.15%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥747.3m

FY2018FY2025

Net income

CN¥389.1m

FY2018FY2025

Free cash flow

CN¥141.6m

FY2018FY2025

Shareholders' equity

CN¥5.66bn

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueCN¥747.3mCN¥649.9mCN¥479.5mCN¥365.5mCN¥331.0mCN¥248.5mCN¥141.5mCN¥97.1m
Gross profitCN¥448.6mCN¥380.8mCN¥292.5mCN¥247.6mCN¥233.6mCN¥181.8mCN¥89.8mCN¥58.1m
Research and developmentCN¥89.1mCN¥75.2mCN¥69.8mCN¥53.8mCN¥29.5mCN¥18.3mCN¥17.4mCN¥14.1m
Operating incomeCN¥106.9mCN¥62.4mCN¥23.1mCN¥17.7mCN¥55.6mCN¥102.2mCN¥44.2mCN¥19.4m
Net incomeCN¥389.1mCN¥366.8mCN¥282.0mCN¥136.5mCN¥47.3mCN¥99.1mCN¥36.4mCN¥16.5m
Diluted earnings per share0.530.500.390.190.070.190.050.02

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsCN¥6.00bnCN¥5.94bnCN¥5.70bnCN¥5.36bnCN¥4.79bnCN¥264.2mCN¥132.4mCN¥81.4m
Cash and short-term investmentsCN¥4.33bnCN¥4.82bnCN¥5.12bnCN¥4.91bnCN¥4.55bnCN¥171.2mCN¥45.3mCN¥19.2m
Total liabilitiesCN¥267.7mCN¥295.1mCN¥289.3mCN¥199.4mCN¥166.8mCN¥88.0mCN¥55.4mCN¥40.7m
DebtCN¥9.2mCN¥22.6mCN¥8.2mCN¥11.3mCN¥13.2mCN¥12.1mCN¥4.8mCN¥7.4m
Shareholders' equityCN¥5.66bnCN¥5.58bnCN¥5.35bnCN¥5.12bnCN¥4.60bnCN¥176.2mCN¥77.1mCN¥40.7m
Shares outstanding734m733m732m734m723m535m690m690m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operationsCN¥156.6mCN¥126.1mCN¥118.5mCN¥89.8mCN¥51.7mCN¥129.2mCN¥32.8mCN¥25.7m
Capital spending−CN¥14.9m−CN¥24.3m−CN¥37.9m−CN¥8.7m−CN¥2.3m−CN¥728,517−CN¥2.8m−CN¥3.6m
Free cash flowCN¥141.6mCN¥101.8mCN¥80.7mCN¥81.1mCN¥49.4mCN¥128.5mCN¥30.0mCN¥22.1m
Dividends paid−CN¥216.0m−CN¥208.4m−CN¥145.1m−CN¥14.1m−CN¥107.1m−CN¥107.1m−CN¥107.1m−CN¥107.1m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥361.8mCN¥384.2mCN¥363.1mCN¥366.6mCN¥283.3mCN¥277.6mCN¥201.9mCN¥211.9m
Gross profitCN¥222.8mCN¥234.5mCN¥214.1mCN¥209.4mCN¥171.5mCN¥170.0mCN¥122.5mCN¥141.4m
Operating incomeCN¥108.5mCN¥70.3mCN¥36.6mCN¥34.5mCN¥27.9mCN¥7.7mCN¥23.4mCN¥60.1m
Net incomeCN¥185.4mCN¥208.3mCN¥180.8mCN¥196.0mCN¥170.7mCN¥167.1mCN¥114.9mCN¥105.1m
Diluted earnings per share0.250.280.250.270.230.230.160.14
Cash from operations—CN¥101.0mCN¥77.0mCN¥102.0mCN¥23.0mCN¥83.0mCN¥35.0mCN¥56.0m
Capital spending—−CN¥1.0m−CN¥11.0m−CN¥12.0m−CN¥1.0m———
Free cash flow—CN¥100.0mCN¥66.0mCN¥90.0mCN¥22.0m———
Total assetsCN¥5.87bnCN¥6.00bnCN¥5.95bnCN¥5.94bnCN¥5.75bnCN¥5.70bnCN¥5.68bnCN¥5.36bn
Cash and short-term investmentsCN¥3.10bnCN¥4.33bnCN¥4.21bnCN¥4.82bnCN¥4.50bnCN¥5.12bnCN¥5.14bnCN¥4.91bn
DebtCN¥2.3mCN¥9.2mCN¥17.4mCN¥26.3mCN¥18.7mCN¥9.5mCN¥9.9mCN¥13.1m
Shareholders' equityCN¥5.58bnCN¥5.66bnCN¥5.63bnCN¥5.58bnCN¥5.45bnCN¥5.35bnCN¥5.36bnCN¥5.12bn

Financial ratios

Data as of 12 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin60.0%58.6%61.0%67.7%70.6%73.2%
Operating margin26.1%21.0%61.5%43.2%24.8%49.2%
Net margin52.1%56.4%58.8%37.4%14.3%39.9%
Return on equity6.9%6.6%5.3%2.7%1.0%56.3%
Return on assets6.5%6.2%5.0%2.5%1.0%37.5%
Free cash flow yield3.0%2.7%2.8%1.7%1.0%3.2%
Revenue growth15.0%35.5%31.2%10.4%33.2%75.6%
Earnings growth6.1%30.1%106.5%188.9%-52.3%172.5%
Current ratio19.09x21.03x24.10x32.78x35.45x3.25x
Debt to equity0.00x0.00x0.00x0.00x0.00x-0.07x
Equity ratio94.3%93.9%93.9%95.6%95.9%66.7%
Interest coverage303.18x149.41x702.20x255.31x131.70x502.67x
R&D as a share of sales11.9%11.6%14.6%14.7%8.9%7.4%
Buybacks as a share of market value-0.1%-0.1%0.3%-1.5%-35.2%22.5%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue26.9%24.6%—
Operating income82.3%0.9%—
Net income41.8%31.4%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin59.4%61.1%63.3%—
Operating margin12.1%9.4%13.0%—
Net margin54.1%52.4%46.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings16.017.219.139.7361.3
Price to sales8.39.711.214.851.6

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 19 May 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year0.1630.2760.270.1910.021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.